Main Article Content

Joseph Miller


Sarcopenia, Muscle Wasting, Muscle, Older Adults, Strength and Function Loss


Objective: Sarcopenia is a growing public health issue with significant personal and societal implications putting older adults at increased risk of physical disability, decreased quality of life, loss of independence and death. Despite its prevalence, sarcopenia is overlooked and undertreated in primary health care settings. This narrative review is an overview of the causes, consequences, prevalence, risk factors, deficits and natural history of sarcopenia.

Method: I searched PubMed, MEDLINE, Scopus and Google Scholar to identify relevant papers published between 1980-2021 using search terms sarcopenia, frailty, muscle wasting, older adults, aging disorders, muscle, strength and function loss.

Results: Papers were screened according to the following eligibility criteria. Population: adults aged 50 and older in community dwelling or institutionalized settings (nursing homes, hospitals); men and women screened for sarcopenia with clear diagnostic criteria; outcome measures related to sarcopenia including strength, muscle mass and physical or functional performance. Study design: systematic review, meta-analysis. Limits: English language, human adults. Studies were diverse. The main reasons for exclusion were papers with younger participants or not including sarcopenia’s effect on related outcomes. Of 1,121 records, a total of 38 papers were included in this review. These papers covered the causes, consequences, prevalence, risk factors, deficits and natural history of sarcopenia. Studies were included based on their relevancy to the chiropractic profession.

Conclusions: There is general agreement that sarcopenia is a commonly overlooked condition that has public health ramifications. Several papers express concern over the lack of attentiveness to this condition, which may have life-altering consequences in older individuals. There is little information regarding the role chiropractors might play with this condition. However, as “portal of entry” health care providers chiropractors may be ideally poised to assist with this condition.


Download data is not yet available.
Abstract 126 | SARCOPENIA Downloads 91


1. Cruz-jentoft AJ, Bahat G, Bauer J et al. Sarcopenia. Revised European consensus on definition and diagnosis. Age Aging 2018;0:1-16
2. Hanna JS. Sarcopenia and critical illness: A deadly combination in the elderly. L Parenter Enteral Nutr 2015;39(3):273-281
3. Janssen I. Influence of sarcopenia on development of physical disability. The Cardiovascular Health Study. J Am Geriatr Soc 2006;54:56-62
4. Mitchell WK, Williams J, Atherton P et al. Sarcopenia, dynapena, and impact of advancing age on human skeletal muscle size and strength. A quantative review. Front Physiol 2012;3:260-271
5. Wilkinson DJ. The age-related loss of skeletal muscle mass and function of muscle fiber atrophy and loss in humans. Ageing Res Rev 2018; 47:123-132
6. Dennison EM,Sayer AA, Cooper C. Epidemology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatal 2017;13(6):340-347
7. Landi F, Liperoti R, Russo A et al. Sarcopenia as a risk factor for falls in elderly individuals. Results for the iISIRENTE Study Cl Nut 2012;31(5):652-658
8. Rosenberg I. Rosenberg Summary Comments. Am J Clin Nutr 1989;50:1231-1233
9. Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al. Sarcopenia: European consensus on definition and diagnosis. Report of the Ueropean Working Group on Sarcopenia in Older People. Age and Ageing 2010;39(4):412-423
10. Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle 2016;7(5):512-514
11. Chen LK, Liu LK, Woo J et al. Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc 2014;15:95-101
12. Peterson MD. Resistance exercise for sarcopenia outcomes and muscular fitness in aging adults. Nat Str Coach Assoc 2020;32(3):52-63
13. Dryer HC, Volpi E. Role of protein and amino acids in pathophysiology and treatment of sarcopenia. J Am Coll Nut 2005;24(2):140s-145s
14. Bunout D, DeLamaza MP, Barrena G. Association between sarcopenia and mortality in health of older people. Australian J Aging 2011;April 64-69.
15. Brown JC, Harhay MO, Harhay MN. Sarcopenia: Mortality among a population-based sample of community dwelling older adults. J Cachexia Sarcopenia Muscle 2016;7(3):290-298
16. Janssen I. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc 2004;52:80-85
17. Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy older men and women. J Geront 2002;57(12):M772-M777
18. Robinson SM, Reginster JY, Rizzoli R et al. Does nutrition play a role in prevention and management of sarcopenia. Cl Nut 2018;37(4):1121-1132
19. Cruz-Jentoft AJ. Relevance of and interventions for sarcopenia in aging adults. A systematic review. Age Ageing 2014;43:748-759
20. Bianchi L, Abete P, Bellelli G et al. Prevalence and clinical correlates of sarcopenia. Identified according to EWGSOP definition and diagnostic algorithm in hospitalized older people. GLISTEN Study. J Geront 2017;72;11:1575-1581
21. Lexall J. Human aging, muscle mass and fiber type composition. J Gerontol A Biol Sci Med Sci 1995;50A:11-16
22. Lang T, Streeper T, Cawthon P, Baldwin K, et al. Sarcopenia. Etiology, clinical consequences, intervention and assessment. Osteop 2010;21(4):543-559
23. Demling RH. Nutrition, anabolism and the wound healing process. An overview. Eplasty 2009;9:e9
24. Delmonico MJ, Harris TB, Visser M. Longitudinal study of muscle strength, quality and adipose tissue infilitration. Am J Clin Nut 2009;90:1579-1585
25. Goodpaster BH, Park SW, Harris TB et al. Loss of skeletal muscle strength, mass in older adults. J Gerontol A Diol Sci Med Sci 2006;61:1059-1064
26. Lynch NA, Metter EJ, Liinde RS et al. Muscle quality: Age associated differences between arm and leg muscle groups. J App Physiol 1985;86:188-194
27. Metter EJ, Conwit R, Metter B. Relationships of peripheral motor nerve conduction velocity to age associated loss of grip strength. Aging 1998;10:471-478
28. Guralnik P. A short physical performance battery assessing lower extremity function. J Geront 1994;49:85-89
29. Martone AM, Marzetti E, Calvani R et al. Assessment of sarcopenia from clinical practice to research. JGG2019;67:39-45
30. Kaiser M, Bauer JM, Ramsch C. Frequency og malnutrition in older adults. A multinational perspective using the mini nutritional assessment. J Am Geriatr Soc 2010;58(9):1734-1738
31. Verlaan S, Aspray TJ, Bauer JM et al. Nutritional status, body composition and quality of life in community dwelling sarcopenic and non-sarcopenic older adults. A case-control study. Clin Nut 2017;36(1):267-274
32. Terborg S, Lisette C, Mijnarends MS et al. Differences in nutrient intake and biochemical nutrient status between sarcopenic and non-sarcopenic older adults. Results from Maastricht Sarcopenia Study. JAMADA 2016;Vol.17,5:393-401
33. Dirks ML, Wall BT. Neuromuscular electrical stimulation prevents muscle disuse atrophy during leg immobilization in humans Acta Physiol 2014;210(3):628-641
34. Kortebein P, Paddon-Jones D, Ronsen O et al. Effect of 10 days of bed rest on body composition and rate of muscle protein synthesis in older men and women. FASEBS 2006;20:A159-A164
35. Krogh-Madsen R, Thyfault JP, Boholm C et al. A two-week reduction of ambulatory activity attentuates peripheral insulin sensitivity. J Appl Physiol 2010;108(5):1034-1040
36. Roh E, Choi KM. Health consequences of sarcopenic obesity. Fr Endocrin 2020;11:332-338
37. Wannamethee SG, Atkins J. Muscle loss and obesity: Health implications of sarcopenia and sarcopenia obesity. Pro Of Nut Soc 2015;74:405-412
38. Kilaru S. Smoking may also negatively effect basis of muscle preservation and restoration. J Am Coll Surg 2001;193(5):538-546